{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T05:51:37Z","timestamp":1725256297115},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jneuroim.2024.578331","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T16:10:05Z","timestamp":1710605405000},"page":"578331","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Three-year follow-up of rheumatoid meningitis with matrix metalloprotease-9 levels in the serum and cerebrospinal fluid as indicators of disease activity: A case report"],"prefix":"10.1016","volume":"390","author":[{"given":"Keishu","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuichi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsoo","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Kajimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidefumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2024.578331_bb0005","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0010","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.3390\/biomedicines10102401","article-title":"Anti-cyclic Citrullinated peptide antibody index in the cerebrospinal fluid for the diagnosis and monitoring of rheumatoid meningitis","volume":"10","author":"Caputi","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jneuroim.2024.578331_bb0015","first-page":"732","article-title":"Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis","volume":"32","author":"Cavazzana","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0020","article-title":"Efficacy of rituximab on rheumatoid Leptomeningitis as the first symptom of rheumatoid arthritis","volume":"8","author":"Chouk","year":"2021","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0025","first-page":"262","article-title":"Self-limited rheumatoid meningitis as a presenting symptom of rheumatoid arthritis","volume":"20","author":"Finkelshtein","year":"2018","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-5728(92)90192-N","article-title":"Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders","volume":"41","author":"Gijbels","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2011.04.009","article-title":"Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier","volume":"236","author":"Hosokawa","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0040","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00296-022-05209-x","article-title":"Rheumatoid meningitis without a history of rheumatoid arthritis: a case report and literature review","volume":"43","author":"Huang","year":"2023","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0045","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00296-009-1266-z","article-title":"Unusual central nervous system involvement of rheumatoid arthritis: successful treatment with steroid and azathioprine","volume":"31","author":"Inan","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0050","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10072-011-0727-9","article-title":"A case of rheumatoid meningitis: pathologic and magnetic resonance imaging findings","volume":"32","author":"Kim","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0055","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5692\/clinicalneurol.cn-001296","article-title":"A case of possible elderly onset rheumatoid meningitis without arthritis","volume":"59","author":"Kira","year":"2019","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2024.578331_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2018.12.001","article-title":"Rheumatoid meningitis sine arthritis","volume":"328","author":"Lee Ching","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s13018-022-03405-w","article-title":"Genetic variant in SPAG16 is associated with the susceptibility of ACPA-positive rheumatoid arthritis possibly via regulation of MMP-3","volume":"17","author":"Lin","year":"2022","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/practneurol-2018-001978","article-title":"Rheumatoid leptomeningitis presenting with an acute neuropsychiatric disorder","volume":"19","author":"Lubomski","year":"2019","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/neup.12238","article-title":"Two cases of rheumatoid meningitis","volume":"36","author":"Magaki","year":"2016","journal-title":"Neuropathology"},{"key":"10.1016\/j.jneuroim.2024.578331_bb0080","first-page":"12","article-title":"Rheumatoid arthritis presenting as rheumatoid meningitis","author":"McKenna","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577396","article-title":"Three cases of rheumatoid meningitis with elevated CSF neopterin levels","volume":"348","author":"Miyaue","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0090","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fneur.2019.00666","article-title":"Use of cerebrospinal fluid biomarkers in diagnosis and monitoring of rheumatoid meningitis","volume":"10","author":"Nissen","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0095","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s10072-015-2075-7","article-title":"Redefining a diagnosis: from meningeal plasma cell granuloma to rheumatoid meningitis. Report of a patient follow-up","volume":"36","author":"Padjen","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1468-1331.1994.tb00051.x","article-title":"Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases","volume":"1","author":"Paemen","year":"1994","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0105","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1007\/s10067-020-05221-1","article-title":"Rheumatoid meningitis and infection in absence of rheumatoid arthritis history: review of 31 cases","volume":"39","author":"Rodriguez Alvarez","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0110","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s11011-021-00758-9","article-title":"Evaluation of matrix metalloproteinase-9 plasma levels in untreated new relapsing-remitting multiple sclerosis patients and their first-degree family","volume":"36","author":"Samangooei","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1212\/CPJ.0000000000000504","article-title":"Rheumatoid meningitis: a rare cause of aseptic meningitis with frequently stroke-like episodes","volume":"8","author":"Schuster","year":"2018","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000447627","article-title":"Anti-cyclic Citrullinated peptide antibody-positive meningoencephalitis in the preclinical period of rheumatoid arthritis","volume":"8","author":"Shibahara","year":"2016","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0130","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000257824.72457.91","article-title":"Clinical manifestations and treatment of rheumatoid pachymeningitis","volume":"68","author":"Starosta","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2024.578331_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.det.2015.03.004","article-title":"Rheumatoid Nodules","volume":"33","author":"Tilstra","year":"2015","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/10409238.2013.770819","article-title":"Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade","volume":"48","author":"Vandooren","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0145","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1111\/ene.14904","article-title":"Rheumatoid meningitis: a systematic review and meta-analysis","volume":"28","author":"Villa","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0150","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.jneuroim.2024.578331_bb0155","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0165-5728(00)00339-8","article-title":"Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count","volume":"110","author":"Yushchenko","year":"2000","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T07:21:51Z","timestamp":1715325711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572824000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":31,"alternative-id":["S0165572824000493"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578331","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-year follow-up of rheumatoid meningitis with matrix metalloprotease-9 levels in the serum and cerebrospinal fluid as indicators of disease activity: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578331"}}